Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $1.45 Million - $2.6 Million
35,055 Added 154.62%
57,726 $2.44 Million
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $23,183 - $30,393
412 Added 1.85%
22,671 $1.57 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $626,803 - $803,616
10,613 Added 91.13%
22,259 $1.65 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $158,124 - $237,497
2,398 Added 25.93%
11,646 $794,000
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $364,546 - $552,810
5,816 Added 169.46%
9,248 $868,000
Q1 2023

May 17, 2023

SELL
$47.19 - $70.77 $3,161 - $4,741
-67 Reduced 1.91%
3,432 $232,000
Q4 2022

Mar 06, 2023

SELL
$30.35 - $53.15 $42,763 - $74,888
-1,409 Reduced 28.71%
3,499 $172,000
Q3 2022

Nov 02, 2022

SELL
$31.97 - $49.37 $4,252 - $6,566
-133 Reduced 2.64%
4,908 $158,000
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $1,566 - $3,354
-44 Reduced 0.87%
5,041 $197,000
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $111,551 - $159,962
1,938 Added 61.58%
5,085 $355,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $554,915 - $770,604
-7,654 Reduced 70.86%
3,147 $244,000
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $1.04 Million - $1.43 Million
-11,495 Reduced 51.56%
10,801 $1.03 Million
Q2 2021

Aug 10, 2021

BUY
$93.66 - $139.27 $531,145 - $789,800
5,671 Added 34.11%
22,296 $2.77 Million
Q1 2021

May 11, 2021

BUY
$116.57 - $155.01 $759,220 - $1.01 Million
6,513 Added 64.41%
16,625 $2.19 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $822,977 - $1.17 Million
8,262 Added 446.59%
10,112 $1.34 Million
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $205,342 - $287,260
-2,816 Reduced 60.35%
1,850 $188,000
Q2 2020

Aug 12, 2020

BUY
$55.75 - $92.75 $131,793 - $219,261
2,364 Added 102.69%
4,666 $406,000
Q1 2020

May 12, 2020

BUY
$37.9 - $104.44 $34,526 - $95,144
911 Added 65.49%
2,302 $134,000
Q4 2019

Feb 07, 2020

BUY
$77.66 - $99.74 $3,184 - $4,089
41 Added 3.04%
1,391 $129,000
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $50,155 - $67,981
555 Added 69.81%
1,350 $122,000
Q2 2019

Aug 09, 2019

BUY
$89.51 - $118.04 $2,058 - $2,714
23 Added 2.98%
795 $94,000
Q1 2019

May 10, 2019

BUY
$61.98 - $96.5 $4,462 - $6,948
72 Added 10.29%
772 $67,000
Q4 2018

Feb 12, 2019

BUY
$56.04 - $82.66 $39,228 - $57,862
700 New
700 $44,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.